- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 9-23 of
131 results
6 Preliminary Response: Patent Owners Preliminary Response
Document
IPR2018-00211, No. 6 Preliminary Response - Patent Owners Preliminary Response (P.T.A.B. Apr. 10, 2018)
|
|
Cite Document
3 Mandatory Notice: Patent Owners Mandatory Notices
Document
IPR2018-00211, No. 3 Mandatory Notice - Patent Owners Mandatory Notices (P.T.A.B. Dec. 22, 2017)
|
|
Cite Document
4 Power of Attorney: Gilead Pharmasset Power of Attorney
Document
IPR2018-00211, No. 4 Power of Attorney - Gilead Pharmasset Power of Attorney (P.T.A.B. Dec. 22, 2017)
|
|
Cite Document
1 Power of Attorney: Power of Attorney
Document
IPR2018-00211, No. 1 Power of Attorney - Power of Attorney (P.T.A.B. Dec. 6, 2017)
|
|
Cite Document
2006 Exhibit: Americas Overspend How the Pharmaceutical Patent Problem Is Fue...
Document
IPR2018-00211, No. 2006-21 Exhibit - Americas Overspend How the Pharmaceutical Patent Problem Is Fueling (P.T.A.B. Apr. 10, 2018)
|
|
Cite Document
2002 Exhibit: Bert M Klebl et al, Host Cell Targets in HCV Therapy Novel Strategy o...
Document
IPR2018-00211, No. 2002-17 Exhibit - Bert M Klebl et al, Host Cell Targets in HCV Therapy Novel Strategy or Proven Practice (P.T.A.B. Apr. 10, 2018)
|
|
Cite Document
2001 Exhibit: File Wrapper for US Patent No 9,393,256
Document
IPR2018-00211, No. 2001-16 Exhibit - File Wrapper for US Patent No 9,393,256 (P.T.A.B. Apr. 10, 2018)
|
|
Cite Document
2003 Exhibit: David L Wyles et al, Synergy of Small Molecular Inhibitors of Hepatitis...
Document
IPR2018-00211, No. 2003-18 Exhibit - David L Wyles et al, Synergy of Small Molecular Inhibitors of Hepatitis C Virus (P.T.A.B. Apr. 10, 2018)
|
|
Cite Document
2006 Exhibit: America¿¿¿s Overspend How the Pharmaceutical Patent Problem Is Fu...
Document
IPR2018-00211, No. 2006-21 Exhibit - America¿¿¿s Overspend How the Pharmaceutical Patent Problem Is Fueling (P.T.A.B. Apr. 10, 2018)
|
|
Cite Document
2005 Exhibit: Press Release, Gilead Sciences, Inc, US Food and Drug Administrati...
Document
IPR2018-00211, No. 2005-20 Exhibit - Press Release, Gilead Sciences, Inc, US Food and Drug Administration (P.T.A.B. Apr. 10, 2018)
|
|
Cite Document
2004 Exhibit: Jacqueline G OLeary Gary L Davis, Hepatitis C Virus Replication and...
Document
IPR2018-00211, No. 2004-19 Exhibit - Jacqueline G OLeary Gary L Davis, Hepatitis C Virus Replication and Potential Targets (P.T.A.B. Apr. 10, 2018)
|
|
Cite Document
2008 Exhibit: Eric Lawitz et al, Development of Sofosbuvir for the Treatment of Hep...
Document
IPR2018-00211, No. 2008-23 Exhibit - Eric Lawitz et al, Development of Sofosbuvir for the Treatment of Hepatitis C Virus Infection (P.T.A.B. Apr. 10, 2018)
|
|
Cite Document
2007 Exhibit: Our People, I MAK 2018
Document
IPR2018-00211, No. 2007-22 Exhibit - Our People, I MAK 2018 (P.T.A.B. Apr. 10, 2018)
|
|
Cite Document
2004 Exhibit: Jacqueline G OLeary Gary L Davis, Hepatitis C Virus Replication and...
Document
IPR2018-00211, No. 2004 Exhibit - Jacqueline G OLeary Gary L Davis, Hepatitis C Virus Replication and Potential Targets (P.T.A.B. Apr. 10, 2018)
|
|
Cite Document
2002 Exhibit: Bert M Klebl et al, Host Cell Targets in HCV Therapy Novel Strategy o...
Document
IPR2018-00211, No. 2002 Exhibit - Bert M Klebl et al, Host Cell Targets in HCV Therapy Novel Strategy or Proven Practice (P.T.A.B. Apr. 10, 2018)
|
|
Cite Document
